This inventor holds 1 USPTO granted patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Siegfried H. Reichi: Innovator in HIV Treatment
Introduction
Siegfried H. Reichi is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of medicine, particularly in the development of treatments for HIV.
Latest Patents
Reichi holds a patent for HIV protease inhibitors. These inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme. This action causes the replication of the HIV virus to terminate. The compounds, along with pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients infected with the HIV virus, which is known to cause AIDS. He has 1 patent to his name.
Career Highlights
Siegfried H. Reichi has worked at Agouron Pharmaceuticals, Inc., where he has been involved in groundbreaking research and development in the pharmaceutical industry. His work has had a profound impact on the treatment of HIV, contributing to advancements in medical science.
Collaborations
Throughout his career, Reichi has collaborated with esteemed colleagues, including Kim F. Albizati and Michael D. Varney. These collaborations have further enhanced the research and development efforts in the field of antiviral treatments.
Conclusion
Siegfried H. Reichi's innovative work in developing HIV protease inhibitors has made a significant impact on the treatment of HIV/AIDS. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile